Genetic Variation (CHRNA5), Medication (Combination Nicotine Replacement Therapy vs. Varenicline) and Smoking Cessation()

OBJECTIVE: Recent evidence suggests that the efficacy of smoking cessation pharmacotherapy can vary across patients based on their genotypes. This study tests whether the coding variant rs16969968 in the CHRNA5 nicotinic receptor gene predicts the effects of combination nicotine replacement therapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Alcohol Depend
Hlavní autoři: Chen, Li-Shiun, Baker, Timothy B., Jorenby, Douglas, Piper, Megan, Saccone, Nancy, Johnson, Eric, Breslau, Naomi, Hatsukami, Dorothy, Carney, Robert M., Bierut, Laura J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537319/
https://ncbi.nlm.nih.gov/pubmed/26142345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.06.022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky